Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism
about
Venous thromboembolism in Latin America: a review and guide to diagnosis and treatment for primary careRoutine deprescribing of chronic medications to combat polypharmacyChanges in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011Capsule commentary on Leiss et al., Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolismEducational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trialPhytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes.Pathogenesis, Diagnosis, and Treatment of Venous Thromboembolism in Older Adults.Development of a refill pattern method to measure polypharmacy in administrative claims databases.Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderlyConcurrent Use of Prescription Drugs and Herbal Medicinal Products in Older Adults: A Systematic Review.Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
P2860
Q26766262-5FAFAC39-45AF-4AF6-8E9B-B087F313A13AQ26775802-658AA4E9-74F2-4117-83ED-DE06B0834921Q28109335-15BC486B-95E4-4370-8434-01BFC2214256Q34826282-241209A6-2139-42F2-BD67-42D43B17E5E5Q36126175-6751ECEC-39E8-40E3-9272-9E75C162B5FAQ37007416-6BA48461-A11D-4E89-AA2E-1CCAECC8A119Q38532642-078A0B70-52DD-4D56-AFF2-055C4417E5E2Q38760067-280BF3A0-F0EF-48EF-8C60-B9240DA64AA3Q38936112-EE47F71D-C230-4C3D-8518-88627CC09695Q39486862-23842E9A-99D9-4E6C-A4A9-C1F954AE846DQ41265471-0D2C6424-6DCD-43B8-A378-98D15D25A501Q47202565-6C39155F-3FC7-4D75-889D-E308D5CFC19CQ58130065-F4E84DEF-FA7E-4CDB-A2F0-E7FDB5C52065
P2860
Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polypharmacy is associated wit ...... ts with venous thromboembolism
@ast
Polypharmacy is associated wit ...... ts with venous thromboembolism
@en
type
label
Polypharmacy is associated wit ...... ts with venous thromboembolism
@ast
Polypharmacy is associated wit ...... ts with venous thromboembolism
@en
prefLabel
Polypharmacy is associated wit ...... ts with venous thromboembolism
@ast
Polypharmacy is associated wit ...... ts with venous thromboembolism
@en
P2093
P2860
P50
P1476
Polypharmacy is associated wit ...... ts with venous thromboembolism
@en
P2093
Beat Frauchiger
Christian M Matter
Drahomir Aujesky
Jacques Cornuz
Joseph Osterwalder
Kurt Jaeger
Marc Husmann
Marc Righini
Markus Aschwanden
Martin Banyai
P2860
P2888
P356
10.1007/S11606-014-2993-8
P577
2014-08-21T00:00:00Z
P6179
1044001563